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Immunology has been an art since time immemo- 
rial, and a science for approximately one hundred 
years. The recent development of immunology has 
been tremendous, even when compared with other 
areas of biology. Much of it has been on a molec- 
ular, i.e. a chemical, level and most recently many 
cellular immunological phenomena became prone 
to a molecular attack. Out of the manifold hot spots 
of immunology the organizers of the 7th Meeting 
of the Federation of European Biochemical Socie- 
ties in Varna (Bulgaria) last September chose the 
Molecular Genetics of Antibody Formation [l] as 
the topic for an immunochemical colloquium 
(organized by M. Sela, Rehovot and M. Yomtov, 
Sofia). The first part of the colloquium dealt with 
the problems of the structural genes for immuno- 
globulins, the generation of their diversity and the 
chemical and serological differences between various 
immunoglobulins, including known antibodies. The 
second part of the colloquium was devoted to the 
determinant-specific genetic control of immune 
responsiveness. 
The efforts to understand the biological expres- 
sion of immunological phenomena through investi- 
gations at a precise chemical level makes it particu- 
larly appropriate to recall the visionary words of 
the great Swedish physical chemist, Svante Arrhenius, 
in his book “Immunochemistry” published in 1907 
[2]. It was Arrhenius who first coined the expres- 
sion immunochemistry. His interest in the immuno- 
logical field was triggered by Paul Ehrlich’s investi- 
gations of the reactions of toxins with antitoxins. 
Arrhenius saw that they obeyed the law of mass 
action and initiated a comprehensive study of the 
problem. But the immunobiologists of that period, 
including Ehrlich himself, became critical of his 
approach. To this, Arrhenius answers in the preface 
of his book [2] : 
“It is evident that the objection recently raised 
by Ehrlich and Sachs to this manner of investigation, 
namely, that it does not enter upon the mode by 
which the living body produces these so-called anti- 
bodies, is quite true. An investigation of the chemi- 
cal relations of toxin and antitoxin need not carry 
with it an elucidation of the synthesis of the anti- 
toxin. But I fancy that there are many who are so 
deeply interested in the chemical behaviour of these 
substances that they will find an investigation of 
this question well worthy of study. And for myself, 
furthermore, I believe that the physiological side 
of the problem, alluded to by Ehrlich, will not find 
a satisfactory solution until the more simple chemi- 
cal aspect is elucidated.” 
N. Hilschmann (Gottingen) presented an impressive 
barrage of monoclonal immunoglobulin sequence 
data from his own laboratory and correlated them 
with information available from other laboratories, 
presenting a convincing case for the germ line theory 
of antibody formation. There was, nevertheless, no 
unanimity of opinion, and F. Franek (Prague) in his 
concluding remarks jokingly suggested that “the 
safest theories are partly germ-line and partly somatic, 
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as their authors will always be able to say that they 
were correct - partly”. Whatever the final validity 
of the various theories, there is no doubt that, due 
to its division into a constant and a variable part, V, 
the genetic control of the immunoglobulin molecule 
is more complicated than with other proteins. It is 
unique in this respect that one immunoglobulin 
peptide chain is controlled by two genes: one for 
the constant and one for the variable part. On the 
basis of a discriminating chemical homology sub- 
groups and “subsubgroups” can be recognized 
within the variable parts. Proteins belonging to one 
subgroup have many more residues in common than 
proteins belonging to different subgroups ( and this 
is true also for subsubgroups). Hilschmann’s argu- 
ment is that this regularity must be caused by evo- 
lution and not by a somatic hypermutation process, 
since independent mutations in different individuals 
would not have occurred in a parallel way. The only 
somatic step Hilschmann admits during cell differ- 
entiation is the fusion of one of the variable genes 
with the corresponding gene for the constant part. 
This process is essential in cell differentiation, form- 
ing a unipotent antibody synthesizing cell from a 
multipotent stem cell. 
The structural basis of allotype specificity in 
rabbit immunoglobulin G was discussed by R.R. 
Porter (Oxford), whose laboratory has investigated 
in detail the Al, A2, A3 locus. Some 12- 14 posi- 
tions in the variable region of the heavy chain show 
a correlation between the amino acid residue present 
and the allotype of the protein. This is true for 
pooled and for individual immunoglobulin prepara- 
tions. The origin of these differences, necessitating 
two base changes of the codon in several cases, im- 
plies that rapid mutation was occurring when they 
arose and yet now they show complete stability. At 
present this seems inexplicable, but, in contrast to 
the conclusions of Hilschmann, Porter thinks that 
it is impossible to reconcile the presence of 14 stable 
amino acid positions in the variable region with the 
germ line theory. 
A serological and chemical study of the same 
group a allotypic specificities in rabbits was described 
by J.W. Prahl (Pasadena) and C.W. Todd (Los Angeles). 
Whereas normally 80-90% of the heavy chains of 
the IgG of a rabbit carry these specificities, they have 
succeeded in suppressing them in rabbits homozygous 
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at the group a locus by embryo transfer to a surrogate 
mother lacking their allotypic genome, followed by 
injecting the resulting neonates with anti-allotype 
serum. The immunoglobulins of rabbits suppressed in 
this manner lack group a specificities, and Prahl calls 
them “blank” immunoglobulins. It is interesting to 
speculate about the structural reasons for the lack of 
cross-reaction of the new immunoglobulin with known 
anti-allotype sera. Are there many new amino acid re- 
placements in the positions characteristic of this 
allotype? Or is it a change in the amino acid sequence 
which causes a transformation of the molecule and 
thus does not allow the reaction? The suppressed 
heavy chain was found to possess a different amino- 
terminal sequence, namely, pyrrolidone carboxylic- 
glutamyl-glutamine. It would be desirable to obtain 
antibodies reacting specifically only with the “blank” 
immunoglobulin. Should all rabbits possess a small 
amount of the blank IgG, this might become worth 
trying, possibly by immunization of other species, 
followed by appropriate immunoadsorptions. 
In contrast to the rabbit, genetic markers of 
human immunoglobulin chains have been found in 
this constant region, and M.W. Turner (London) re- 
ported on his and J.B. Natvig’s (Oslo) successful 
efforts to map the markers more precisely by using 
pepsin-produced segments. The role of steric con- 
formation in preserving the genetically relevant anti- 
genie determinants is apparent from the loss of reac- 
tion upon further proteolytic digestion. 
Most interesting was the talk by J. Oudin (Paris), 
the discoverer of rabbit allotypes and idiotypes. 
Idiotypy of antibodies is their property of possess- 
ing antigenic specificities which differ according to 
the antigens against which they are directed and 
according to individuals, or perhaps groups of indi- 
viduals, in which they are produced. The antigens 
used by Oudin were Salmonella typhi, Salmonella 
abortus-equi and ovalbumin. The same idiotypic 
pattern has been observed in antibodies of a unique 
specificity which belonged to the IgG and IgM 
classes. Idiotypy may change with the course of 
immunization as was shown by, for example, that 
two idiotypic patterns which are carried by two 
distinct molecules may be carried in serum from a 
previous bleeding by a single molecule. A particular- 
ly fascinating novel observation from Oudin’s labo- 
ratory is that the same idiotypic specificity may be 
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found on antibodies differing in their affinity and 
possibly even in their specificity. This conclusion 
was arrived at from careful studies of anti-ovalbumin 
antibodies, including selective immunoadsorption and 
elution according to different antigenic determinants 
(using duck, turkey and hen ovalbumin) and different 
affinities (using different molarities of magnesium 
chloride for elution). Are the immunoglobulins 
possessing the same idiotype, but apparently devoid 
of any anti-ovalbumin reactivity, antibodies with some 
other antigenic specificity, or are they failed anti- 
ovalbumins? 
A.R. Williamson (London) described the use of 
antibody isoelectric spectra as phenotypic markers 
for the variable regions of anti-hapten antibodies. 
The question asked was: how many different anti- 
hapten (NIP) molecules can an inbred strain of mice 
(CBA) make? A cell transfer system was used to dis- 
tribute the secondary response among many recipients 
such that each had about two clones, on the average. 
A large number of unique antibodies were seen with 
a low incidence ( < 2%) of repetition of the same 
antibody from different donors. At this stage William- 
son concludes that the total possible number of anti- 
NIP molecules should be between lo4 and 10’. This 
large number could, however, be generated by only 
200 variable regions each for light and heavy chains. 
Such a number of variable genes could easily be 
carried in the germ-line. 
The immune state of an individual is not in itself 
an inherited characteristic. Nevertheless, the ability 
of an animal to elicit an immune response to a 
specific immunogen is subject to genetically de- 
termined factors. Results of investigations reported 
during the last decade have indicated that the 
immune response potentials of several rodent species 
to natural and synthetic immunogens are under 
genetic regulation [3]. While the whole subject of the 
genetic control of immune response has been under 
vigorous investigation only in the last few years, it 
is pertinent to recall that the topic was mentioned in 
the literature as early as 19 16, when Cooke and Van- 
der Veer, Jr., published a paper entitled “Human 
Sensitization” [4]. I quote: “It has been found 
that in cases of bilateral inheritance a larger pro- 
portion of the children become sensitized at an 
average arlier age than in cases of unilateral not- 
withstanding the fact that in more than one-third 
of the former group the hereditary influence on one 
side of the family was not seen in the parent, but in 
a grandparent or a collateral, such as an uncle. It is 
apparent here that the parent not clinically affected 
has transmitted some characteristic to his offspring 
the nature of which cannot be specified. It is how- 
ever conceivable that such parents have latent 
sensitization.” The authors then ask themselves 
whether their cases “might conform to the Mendelian 
laws either as a dominant or as a recessive character- 
istic” and conclude that their data strongly “suggest 
that sensitization is inherited as a dominant charac- 
teristic.” 
The first example in which unigenic control of 
immune response has been demonstrated is the 
“PLL gene” in guinea pigs [3]. In this system, the 
genetic regulation of the immune response to poly-L- 
lysine and to a random copolymer of L-glutamic 
acid and L-lysine, as well as hapten conjugates of 
these polymers, was found to be determined by a 
single autosomal gene. A dominant, quantitative, de- 
terminant-specific genetic control of antibody 
response has been observed in inbred mouse strains 
using branched chain synthetic polypeptide immuno- 
gens in which short peptides of glutamic acid and 
tyrosine, histidine or phenylalanine were attached 
to DL-alanine side chains, which were linked to a 
poly-L-lysine backbone. Mice of the C57BL strain 
were found to be high responders to the tyrosine- 
containing polypeptide, abbreviated as (T,G)-A--L, 
whereas they were low responders to the macromole- 
cule containing histidine, (H,G)-A--L. Conversely, 
CBA mice were high responders to (H,G)-A--L, but 
low responders to (T,G)-A--L. The (C57 X CBA) Fr 
hybrids responded well to both immunogens, and 
the backcross progeny segregated in response to 
(T,G)-A--L and (H,G)-A--L as a I : 1 mixture of the 
F, and respective homozygous parents. 
Expression of genetic control of immune respon- 
siveness has been demonstrated at the cellular level, 
since irradiated low responder mice and guinea pigs 
generated responses characteristic of the high re- 
sponder strains after injection of lymphoid cells from 
high responder donors. The response potentials of 
guinea pigs for poly-L-lysine and of mice for the 
A--L series of immunogens are both closely linked 
to the respective major histocompatibility regions 
of these two species. The responses of inbred mice 
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were different and not linked to H-2 when the poly- 
DL-alanine side chains were replaced with poly-L- 
proline, even though the same short peptide se- 
quences were attached to polyproline. Genetic con- 
trol of antibody specificity has been demonstrated 
using the synthetic polypeptide poly-(Phe, Glu)-poly- 
Pro--poly-Lys, denoted (phe, G)-Pro--L. Two dif- 
ferent mouse strains responded well to (Phe, G)-Pro-- 
L, but the antibodies elicited were of different spe- 
cificities. DBA/ 1 mice responded mainly to the 
(Phe,G) part of the immunogen, whereas most of 
the antibodies produced in the SJL strain were spe- 
cific for Pro--L. 
M. Sela (Rehovot) described studies, with E. Mazes 
and G.M. Shearer, in which it was established that the 
low immune response to the (Phe,Glu) and the poly- 
proline regions of (Phe, G)-Pro--L could be correlated 
with a reduced number of detectable splenic antigen- 
sensitive precursors. The reduction in frequency could 
be attributed to the population of cells derived from 
bone marrow, and not from thymus. On the other 
hand, using the same techniques involving transfer 
into irradiated recipients of graded inocula of cells 
of one type from syngeneic donors while giving an 
excess of cells of the other type (thymus versus 
bone marrow), it could be shown that in the case of 
(T, G)-A--L the genetic defect is expressed in cells 
derived both from thymus and bone marrow. 
Immune response to antigens based on poly- 
proline could be corrected in the poor responder 
strains of mice with the double-stranded polyadenyl- 
ic-polyuridylic acid, as well as with peritoneal exu- 
date cells. Neither of these two was able to influence 
the poor response to antigens based on poly-DL- 
alanine. From these, and other observations, it was 
concluded that the mechanism of the genetic con- 
trol of immune response depends heavily on the 
chemical structure of the immunogen. 
I. &a (Prague) reported on dominant genetically 
controlled differences in antibody formation in mice 
towards two haptens: p-aminobenzoic acid and 
sulfanilic acid. The differences in anti-hapten response 
were not due to differences in the immunogenicity 
of the protein-carrier in individual strains. In agree- 
ment with Sela’s report on the genetic control of 
antibody response to polyproline-derived antigens 
(but not polyalanine-derived) &a finds that the 
bone marrow cells are mainly responsible for the 
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high or low response to the hapten. &a believes 
that the genetic defect is on the level of presence 
or absence of some structural genes, leading in the 
poor responders to antibodies of lower affinity and/or 
more restricted heterogeneity. It seems to me that 
the distinct possibility that the same structural genes 
are present both in low and high responder strains, and 
that the genetic control of the immune response occurs 
at some step other than the structural gene, cannot at 
this stage be discarded, and should be actively inves- 
tigated. 
Another interesting report was that of E. Kolsch 
(Hamburg) on the genetics of immune response to 
bacteriophage fd in mice. The genetic defect is de- 
terminant-specific, and not linked to H-2 specificity 
locus. The heterogeneity of antibodies produced in 
the low responder strains is more restricted than in 
the high responders. Polyacrylic acid restores the 
immune response to fd in some strains, but not in 
others. 
Genetically predetermined differences in anti- 
body formation in inbred strains of mice in response 
to immunization with non-pathogenic leptospirae and 
with sheep red blood cells were observed by R.V. 
Petrov (Moscow) and his colleagues. Even though 
Dr. Petrov did not attend the meeting he made a 
copy of his presentation available to the organizers. 
For both antigens the high response capacity was in- 
herited as a dominant tra.it controlled by more than 
one gene. From experiments with cell transfers into 
lethally irradiated mice Petrov concludes that certain 
cells of recipients are radio-resistant and that their 
presence is crucial in immune response. His working 
hypothesis is that this cell is the macrophage. 
It may be said in conclusion that we are still 
largely in the dark concerning the nature and me- 
chanism of the genetic control of immune respon- 
siveness, even though a lot of important information 
has been accumulated very recently. Let us hope 
that before the next FEBS Meeting convenes a clue will 
be found that will permit at least more informed 
guesses concerning this fascinating phenomenon. 
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